Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

The reliability of provocative stimuli of GH secretion in the diagnosis of GH deficiency is still controversial. Until now, normative values of GH response to various stimuli have not been established properly. In 472 children and adolescents with normal stature (n = 295, height SDS range -1.5 to 1.2) or normal short stature (n = 177, height SDS range -3.7 to -1.8), we studied the GH response to physical exercise, insulin-induced hypoglycemia, arginine (ARG), clonidine, levodopa, glucagon, pyridostigmine (PD), GHRH, PD + GHRH, and ARG + GHRH. The peak GH responses (range) to various stimuli were: 1) physical exercise: 3.0-28.3 micrograms/L; 2) insulin-induced hypoglycemia: 2.7-46.4 micrograms/L; 3) ARG: 0.5-48.4 micrograms/L; 4) clonidine: 3.8-86.0 micrograms/L; 5) levodopa: 1.9-40.0 micrograms/L; 6) glucagon: 1.9-49.5 micrograms/L; 7) PD: 2.5-35.0 micrograms/L; 8) GHRH: 2.7-102.7 micrograms/L; 9)PD + GHRH: 19.6-106.0 micrograms/L; and 10) ARG + GHRH: 19.4-120.0 micrograms/L. Our results show that all conventional stimuli of GH secretion frequently failed to increase GH levels, showing values lower than that arbitrarily assumed, so far, as minimum normal GH peak, i.e. 7 or 10 micrograms/L. When combined with PD or ARG (substances inhibiting hypothalamic somatostatin release), GHRH becomes the most powerful test to explore the secretory capacity of somatotrope cells (the GH response being always higher than 19 micrograms/L). Therefore, only GHRH combined with PD or ARG may be able to clearly differentiate normal children from patients with GH deficiency, though a normal GH response to these tests cannot rule out the existence of GH hyposecretory state because of hypothalamic dysfunction.

[1]  S. Melmed,et al.  Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. , 1995, The Journal of clinical endocrinology and metabolism.

[2]  F. Cassorla,et al.  The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. , 1994, The Journal of clinical endocrinology and metabolism.

[3]  F. Dammacco,et al.  Somatotropic function in short stature: Evaluation by integrated auxological and hormonal indices in 214 children , 1993 .

[4]  S. Loche,et al.  The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation , 1991, Journal of endocrinological investigation.

[5]  Z. Zadik,et al.  Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. , 1990, The Journal of clinical endocrinology and metabolism.

[6]  E. Ghigo,et al.  ARGININE POTENTIATES THE GHRH‐ BUT NOT THE PYRIDOSTIGMINE‐INDUCED GH SECRETION IN NORMAL SHORT CHILDREN. FURTHER EVIDENCE FOR A SOMATOSTATIN SUPPRESSING EFFECT OF ARGININE , 1990, Clinical endocrinology.

[7]  E. Arvat,et al.  A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone , 1990, Journal of endocrinological investigation.

[8]  J. Devesa,et al.  REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC‐SOMATOTROPH RHYTHM (HSR) , 1989, Clinical endocrinology.

[9]  G. Nisticó,et al.  Brain Messengers and the Pituitary , 1989 .

[10]  F. Cassorla,et al.  The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. , 1988, The New England journal of medicine.

[11]  C. Diéguez,et al.  GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES , 1988, Clinical endocrinology.

[12]  F. Diamond,et al.  Growth hormone neurosecretory dysfunction. , 2020, Clinics in endocrinology and metabolism.

[13]  E. Ghigo,et al.  Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. , 1986, The Journal of endocrinology.

[14]  D. Shulman,et al.  Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. , 1986, The Journal of clinical endocrinology and metabolism.

[15]  M. Thorner,et al.  Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH. , 1986, The Journal of clinical endocrinology and metabolism.

[16]  E. Ghigo,et al.  Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects. , 1986, Neuroendocrinology.

[17]  Z. Zadik,et al.  Do short children secrete insufficient growth hormone? , 1985, Pediatrics.

[18]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[19]  W. Mendelson,et al.  Growth hormone neurosecretory dysfunction. A treatable cause of short stature. , 1984, JAMA.

[20]  A. Grossman,et al.  NALOXONE INHIBITS EXERCISE‐INDUCED RELEASE OF PRL AND GH IN ATHLETES , 1983, Clinical endocrinology.

[21]  S. Frasier A preview of growth hormone stimulation tests in children. , 1974, Pediatrics.